People · Operator
Named in public records as an officer, director or promoter · active 2010–2023 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aeovian Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $125.0M | $297.8M | 2023 |
| iPierian, Inc. | — | Pharmaceuticals | Series B | $87.3M | $985.1M | 2010 |
Matthew J. Plunkett at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew J. Plunkett on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Walker | 1 | 17 |
| Beth Seidenberg | 1 | 15 |
| Michael Powell | 1 | 14 |
| Corey Goodman | 1 | 13 |
| Jens Eckstein | 1 | 8 |
| Richard Gaster | 1 | 7 |
| Ben Zadik | 1 | 6 |
| David Lowe | 1 | 5 |
| Beth F. Seidenberg | 1 | 4 |
| Corey S. Goodman | 1 | 4 |
| Robert F Higgins | 1 | 3 |
| James Peyer | 1 | 3 |
| Berta Strulovici | 1 | 2 |
| Michael Venuti | 1 | 2 |
| Ian Massey | 1 | 2 |
| Bob Higgins | 1 | 2 |
| Richard C. Gaster | 1 | 1 |
| Lars C. Ekm | 1 | 1 |
| Stelios Tzannis | 1 | 1 |
| Berta J. Strulovici | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.